you will notice that the .55log results are for m184v + >3 TAMS... ie these are ppl that have developed significant resistant to current drugs. admittedly Racivir does better in these ppl with a .7log drop. however the bulk of the market remains in the m184v +<3 space... ie those ppl with drug resistance... but not huge drug resistance. it is in this space that ACT excels with 1.1log drop the best result in its class (NRTI)
- Forums
- ASX - By Stock
- AVX
- presentation
presentation, page-4
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVX (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online